Of the 1.2 million Americans with human immunodeficiency virus in 2011, 70% did not have their condition under control.
A drug therapy for epilepsy and shingles pain is being voluntarily recalled by its manufacturer due to complaints of empty capsules.
The FDA approved Valeant Pharmaceutical International’s clindamycin phosphate and benzoyl peroxide 1.2%/3.75% today for the once-daily treatment of both non-inflammatory and inflammatory acne in patients 12 and older.
A student pharmacist wrote an open letter to a radio station after a host disparaged the profession with complaints that ranged from the time he had to wait in line for his Z-Pak medication to the placement of contraceptives near the pharmacy counter, according to Buzzfeed.
Citing a risk of spreading unsuspected cancer, the FDA is advising against the use of laparoscopic power morcellators in the removal of the uterus or fibroids in the majority of women.
Community chain pharmacies vary in the barriers they face when implementing programs to improve medication therapy management.
Amgen has discontinued its studies on rilotumumab in advanced gastric cancer after an increased number of deaths were reported among patients receiving rilotumumab and chemotherapy, compared with those only undergoing chemotherapy.